Does DEXLANSOPRAZOLE Cause Rebound acid hypersecretion? 1,160 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,160 reports of Rebound acid hypersecretion have been filed in association with DEXLANSOPRAZOLE (Dexlansoprazole). This represents 4.8% of all adverse event reports for DEXLANSOPRAZOLE.
1,160
Reports of Rebound acid hypersecretion with DEXLANSOPRAZOLE
4.8%
of all DEXLANSOPRAZOLE reports
139
Deaths
108
Hospitalizations
How Dangerous Is Rebound acid hypersecretion From DEXLANSOPRAZOLE?
Of the 1,160 reports, 139 (12.0%) resulted in death, 108 (9.3%) required hospitalization.
Is Rebound acid hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEXLANSOPRAZOLE. However, 1,160 reports have been filed with the FAERS database.
What Other Side Effects Does DEXLANSOPRAZOLE Cause?
Chronic kidney disease (15,973)
Acute kidney injury (7,599)
Renal failure (6,618)
End stage renal disease (4,800)
Renal injury (4,320)
Tubulointerstitial nephritis (2,177)
Death (1,417)
Gastrooesophageal reflux disease (1,013)
Drug ineffective (859)
Nephrogenic anaemia (825)
What Other Drugs Cause Rebound acid hypersecretion?
ESOMEPRAZOLE (2,501)
OMEPRAZOLE (2,350)
LANSOPRAZOLE (1,713)
PANTOPRAZOLE (1,581)
OMEPRAZOLE\SODIUM BICARBONATE (95)
RABEPRAZOLE (64)
RANITIDINE (29)
FAMOTIDINE (12)
ESOMEPRAZOLE\NAPROXEN (9)
Which DEXLANSOPRAZOLE Alternatives Have Lower Rebound acid hypersecretion Risk?
DEXLANSOPRAZOLE vs DEXMEDETOMIDINE
DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE
DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE\SERDEXMETHYLPHENIDATE
DEXLANSOPRAZOLE vs DEXPANTHENOL
DEXLANSOPRAZOLE vs DEXRAZOXANE